Business
AI summaryGubra A/S is a techbio company focused on peptide-based drug discovery and preclinical contract research across Europe, North America and other regions. It operates through three segments—Preclinical Contract Research, Biotech and Gubra Green—offering in vivo pharmacology, biomarker assays, bioinformatics, sequencing and AI-supported histology, alongside its own drug-candidate portfolio and green-transition investments. Partners include Boehringer Ingelheim, Camurus and Amylyx Pharmaceuticals. The company is headquartered in Horsholm, Denmark.
